How is the Inhibikase Therapeutics Inc today?

The Inhibikase Therapeutics Inc today is trading in the down by -3.38% at 2.29.

Inhibikase Therapeutics Inc XNAS: IKT

Inhibikase Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Inhibikase Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Inhibikase Therapeutics Inc
Rating: 1.49975
Author: Trendlyne DVM scores

Download real time

2.29 -0.08 (-3.38%)

45.48% Fall from 52W High

104.8K XNAS Volume

XNAS 28 Mar, 2025 4:00 PM (EDT)

Board Meeting

The board meeting for Inhibikase Therapeutics Inc is scheduled for today, for the purpose of Inhibikase Therapeutics Inc Fourth Quarter Earnings Conference Call for 2024 See details

Not Eligible

-

Expensive Valuation

0.0 / 100

Technically Moderately Bullish

60.0 / 100

No estimates available

Inhibikase Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Inhibikase Therapeutics Inc FAQ

How is Inhibikase Therapeutics Inc today?

Inhibikase Therapeutics Inc today is trading in the red, and is down by -3.38% at 2.29.

How has Inhibikase Therapeutics Inc performed historically?

Inhibikase Therapeutics Inc is currently trading down -3.38% on an intraday basis. In the past week the stock fell -5.37%. stock has been down -22.90% in the past quarter and fell -0.43% in the past year. You can view this in the overview section.